IP Library Granted Patent US 11,284,801
Granted Patent B2
US 11,284,801 · App. 16/356,766 · Granted Mar 29, 2022

Quantification and analysis of angiography and perfusion

Inventors: T. Bruce Ferguson, Jr. (Raleigh, NC); Cheng Chen (Greenville, NC)
Assignee: Stryker European Operations Limited
A61B5/0071A61B5/0261A61B5/0275A61K49/0034A61B2505/05A61B2576/023G06T7/0016G06T2207/10064G06T2207/30104
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,284,801
App. No.
16/356,766
Granted
Mar 29, 2022
Kind
B2
Abstract

A method to visualize, display, analyze and quantify angiography, perfusion, and the change in angiography and perfusion in real time, is provided. This method captures image data sequences from indocyanine green near infra-red fluorescence imaging used in a variety of surgical procedure applications, where angiography and perfusion are critical for intraoperative decisions.

Claims (27)

1. A method for visualizing blood flow in tissue before and after a surgical intervention, the method comprising:

receiving a first image data sequence comprising a plurality of fluorescence images of the tissue before the surgical intervention, wherein the first image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

receiving a second image data sequence comprising a plurality of fluorescence images of the tissue after the surgical intervention, wherein the second image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

synchronizing the first and second image data sequences based on peak fluorescence intensities of average intensity vs. time curves of the first and second image data sequences to align at least a portion of the full phase angiography cycle of the first image data sequence with the corresponding portion of the full angiography cycle of the second image data sequence;

determining, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences; and

displaying, in real time, the synchronized image data sequences and the determined amount of perfusion change on a display.

2. The method of claim 1 , wherein the tissue is a blood vessel, and the blood vessel is a coronary artery bypass graft.

3. The method of claim 1 , wherein the tissue is selected from the group consisting of myocardium during revascularization, breast tissue during reconstruction and bowel tissue during anastomosis.

4. The method of claim 1 , wherein the full phase angiography cycle of blood flow comprises an arterial phase, a microvascular phase, and a venous phase.

5. The method of claim 4 , wherein synchronizing the first and second image data sequences comprises correlating, between the first and second image data sequences, at least one of the arterial phase, microvascular phase, and venous phase.

6. The method of claim 1 , wherein synchronizing the first and second image data sequences comprises calculating a correlation coefficient at each alignment time position and synchronizing the first and second image data based on the largest correlation coefficient.

7. The method of claim 1 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences comprises comparing relative fluorescence intensity between the synchronized first and second image data sequences.

8. The method of claim 1 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences comprises estimating a change of baseline fluorescence intensity difference over the synchronized image data sequences, and adjusting the synchronized image data sequences based on the change in baseline fluorescence intensity.

9. The method of claim 1 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences comprises estimating the perfusion level based on average fluorescence intensity above a threshold.

10. The method of claim 9 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences further comprises estimating the number of image pixels having fluorescence intensity above the threshold.

11. A system for visualizing blood flow in tissue before and after a surgical intervention, comprising:

a processor that:

receives a first image data sequence comprising a plurality of fluorescence images of the tissue before the surgical intervention, wherein the first image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

receives a second image data sequence comprising a plurality of fluorescence images of the tissue after the surgical intervention, wherein the second image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

synchronizes the first and second image data sequences based on peak fluorescence intensities of average intensity vs. time curves of the first and second image data sequences to align at least a portion of the full phase angiography cycle of the first image data sequence with the corresponding portion of the full phase angiography cycle of the second image data sequence; and

determines, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences; and

a display for displaying, in real time, the synchronized image data sequences and the determined amount of perfusion change.

12. The system of claim 11 , wherein the full angiography cycle of blood flow comprises an arterial phase, a microvascular phase, and a venous phase, and the processor synchronizes the first and second image data sequences by correlating, between the first and second image data sequences, at least one of the arterial phase, microvascular phase, and venous phase.

13. The system of claim 11 , wherein the processor synchronizes the first and second image data sequences by calculating a correlation coefficient at each alignment time position and synchronizing the first and second image data based on the largest correlation coefficient.

14. The system of claim 11 , wherein the tissue is a blood vessel and the processor determines, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences before and after the surgical intervention by comparing relative fluorescence intensity between the synchronized first and second image data sequences.

15. The system of claim 11 , wherein the processor determines, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences before and after the surgical intervention at least in part by estimating the perfusion level based on average fluorescence intensity above a threshold.

16. The system of claim 15 , wherein the processor determines, in real time, an amount of perfusion change in the tissue based on the synchronized image data sequences at least in part by estimating the number of image pixels having fluorescence intensity above the threshold.

Assignments (13)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2019
From: FERGUSON, T. BRUCE, JR.; CHEN, CHENG
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 048960/0188 →
MERGER AND CHANGE OF NAME Recorded Apr 22, 2019
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 048979/0191 →
Continuity (3)
Continuation 13922996 · Jun 20, 2013
Provisional Application 61662885 · Jun 21, 2012
Related Publication 20190374106A1 · Dec 12, 2019
Cited By (1)
US 12,186,055